Based on existing research on the combined application of TRPV1 agonists and corresponding antagonists in cervical cancer and lung cancer cell [34,35], it is a very meaningful work to carry out TRPV1-related therapeutic targets for the treatment of cervical cancer. This evidence concerns the gene TRPV1 and cervical carcinoma.